Keyword: Johnson & Johnson

News

Abbott Sticks to 2012 View, Despite Stronger Dollar

18.07.2012 - Abbott Laboratories reported quarterly earnings roughly in line with Wall Street expectations and stuck to its 2012 profit view despite the harsh effects of the stronger dollar, in...

News

Johnson & Johnson Now Expects Synthes Deal to Boost Profit

13.06.2012 - Johnson & Johnson said it expects to complete its $19.7 billion purchase of Swiss medical device maker Synthes on Thursday and that the deal will slightly boost company profit this...

News

Britain to Fund Prostate Cancer Pill in U-turn

16.05.2012 - Britain's drug watchdog has reversed a controversial decision not to fund a new prostate cancer pill that was developed in the country after maker Johnson & Johnson agreed a new...

News

US Senate Probes Painkiller Makers, Allied Groups

10.05.2012 - A U.S. Senate panel has launched a probe of possible links between three drugmakers and nonprofit medical groups that advocated for increasing the use of prescription painkillers...

News

New J&J CEO Parachuting Into Tough Terrain

26.04.2012 - Johnson & Johnson is sending in a former Army Ranger to clean up several big messes that have hurt its reputation, earnings and share price in the past three years. Alex Gorsky...

News

Biosimilar Remicade Accepted for EU Drug Review

13.04.2012 - Europe's drugs watchdog is to evaluate a copycat version of the best-selling biotech drug Remicade, used to treat arthritis, in a move that underscores how the market for so-called...

News

Cardinal Hires New Head of Medical Business

10.04.2012 - Cardinal Health has named a former longtime Johnson & Johnson executive as the new head for its $9 billion medical products and services business, the U.S. pharmaceutical...

News

Avon Names J&J's Sherilyn McCoy as CEO

09.04.2012 - Avon Products named Johnson & Johnson senior executive Sherilyn McCoy to be its new CEO, presenting Coty with another hurdle in its $10 billion bid for the world's largest direct...